Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6689)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2019 (publication date) through Apr 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zeng Y, Yu W, Liu Q, Yu WW, Zhu ZF, Zhao WX, Liu J, Wang JM, Fu XL, Liu Y, Cai XW. Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy. World J Gastrointest Oncol 2019; 11(12): 1172-1181 [PMID: 31908722 DOI: 10.4251/wjgo.v11.i12.1172] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i12/1172.htm |
| Number | Citing Articles |
| 1 |
Vonetta M. Williams, Christopher L. Hallemeier, Krishan R. Jethwa, J. Eva Selfridge, Pari Shah, Christopher J. Anker, Gerard Abood, Dmitriy Akselrod, Jordan Berlin, Ed Kim, Timothy Kennedy, Percy Lee, Navesh Sharma, Small William, Leila Tchelebi, Suzanne Russo. Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus. American Journal of Clinical Oncology 2025; 48(4): 163 doi: 10.1097/COC.0000000000001165
|
| 2 |
Yichun Wang, Fan Wang. <p>Postoperative Radiotherapy for Thoracic Esophageal Carcinoma with Upfront R0 Esophagectomy</p>. Cancer Management and Research 2020; : 13023 doi: 10.2147/CMAR.S286074
|
| 3 |
Jing Cai, Shan Zhou, Yuxi Luo, Anwen Liu. Effect and safety of anlotinib combined with S-1 for recurrent or metastatic esophageal cancer patients who refused or were intolerant to intravenous chemotherapy. Medicine 2021; 100(51): e28126 doi: 10.1097/MD.0000000000028126
|
| 4 |
Juan Li, Rong Qiu, Yuanping Hu, Yuxiang Wang, Zhan Qi, Ming He, Yuekao Li, Luca Bertero. Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/8571438
|
| 5 |
Dan Han, Jing Tian, Junfeng Zhao, Shaoyu Hao. Optimal Treatment Strategies for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Triple Cohort Analysis Using Propensity Score Matching. International Journal of General Medicine 2023; : 5467 doi: 10.2147/IJGM.S440270
|
| 6 |
Ming He, Zhan Qi, Rong Qiu, Yuanping Hu, Juan Li, Yuekao Li, Yuxiang Wang, Pierfrancesco Franco. Correlates of Long-Term Survival of Patients with pN+ Esophageal Squamous Cell Carcinoma after Esophagectomy. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/6675691
|
| 7 |
Chunyang Song, Shuchai Zhu, Jinrui Xu, Jingwei Su, Xueyuan Zhang, Wenzhao Deng, Xiaohan Zhao, Wenbin Shen. Patterns of failure and long-term outcome of postoperative radiotherapy on the survival of patients with pathological T3N0M0 esophageal cancer. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.959568
|